• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHEN ZHEN BALE ELECTRONICS CO.,LTD HEALTH SMART WATCH; INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHEN ZHEN BALE ELECTRONICS CO.,LTD HEALTH SMART WATCH; INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY Back to Search Results
Model Number EP03
Device Problems Product Quality Problem (1506); Device Sensing Problem (2917)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/12/2024
Event Type  malfunction  
Event Description
Bought smart watch that said measures blood glucose levels.It's totally doesn't.It has predetermined blood glucose cycle, have no effect on what and when you eat.Reference report: mw5152226.
 
Event Description
Additional information received on 15-mar-2024, for mw5152227.Correcting procode information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEALTH SMART WATCH
Type of Device
INSTRUMENT, GLUCOSE, NONINVASIVE TECHNOLOGY
Manufacturer (Section D)
SHEN ZHEN BALE ELECTRONICS CO.,LTD
wanzhongcheng clothing wholesale market xinniu community, minzhi street
room b335
longhua district, shenzhen
CH 
MDR Report Key18816611
MDR Text Key336822080
Report NumberMW5152227
Device Sequence Number1
Product Code NCT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/22/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received02/29/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberEP03
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
LIPITOR.; METFORMIN.; ONE A DAY VITAMINS.; VALSARTAN.
Patient Outcome(s) Other;
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-